Articles
A scorecard for osteoporosis in Canada and seven Canadian provinces
- Journal/Conference:
- Osteoporosis International
- Author(s):
- DL Kendler, JD Adachi, JP Brown, AG Juby, CS Kovacs, C Duperrouzel, RK McTavish, C Cameron, L Slatkovska, N Burke
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Skeletal
Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses
- Journal/Conference:
- Current Medical Research and Opinion
- Author(s):
- Samjoo IA, Worthington E, Haltner A, Spin P, Drudge C, Cameron C, Brennan R, Dahlke F, Adlard N
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Multiple Sclerosis, Nervous System
European Guidelines and Real-World Evidence of Maintenance Treatments for Adults with Acute Myeloid Leukemia in First Complete Remission.
- Journal/Conference:
- European Hematology Association Annual Meeting
- Author(s):
- Ahmed M, Thompson G, Martin C, Cameron H, Chen C
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Oncology
Matching Adjusted Indirect Comparison (MAIC) of Oral Azacitidine (Oral-AZA) Versus Injectable AZA in Patients (pts) with Acute Myeloid Leukemia (AML) in First Remission after Intensive Induction Chemotherapy.
- Journal/Conference:
- Blood 138 (Supplement 1): 3015
- Author(s):
- Chen, C.; Huls, GA.; Cameron, H.; Suero, B.; Vasconcelos A.; Gaugler, L.; Beach, C.L.
- Publication Date:
- 2021
- Topic/Therapeutic Area:
- Oncology
PND2 Indirect Treatment Comparisons of Apomorphine Sublingual Film Versus Apomorphine Subcutaneous Injection for the on-Demand Treatment of “Off” Episodes in Patients with Parkinson’s Disease
- Journal/Conference:
- Value in Health
- Author(s):
- Lenton, S.; Singh, S.; Szafranski, K.; Situ, A.; Thatch, A.; Pappert, E.; Williams, GR
- Publication Date:
- 2020
The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis
- Journal/Conference:
- Current medical research and opinion
- Author(s):
- Samjoo, I.A.: Worthington, E.: Haltner, A.: Cameron, C.: Nicholas, R.: Dahlke, F.: Adlard, N.
- Publication Date:
- 2020
- Topic/Therapeutic Area:
- Multiple Sclerosis
Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple scelrosis
- Journal/Conference:
- Current medical research and opinion
- Author(s):
- Samjoo, I. A.: Worthington, E.: Haltner, A.: Cameron, C.: Nicholas, R.: Rouyrre, N.: Dahlke, F.: Adlard, N.
- Publication Date:
- 2020
- Topic/Therapeutic Area:
- Multiple Sclerosis
Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis
- Journal/Conference:
- Journal of Comparative Effectiveness Research
- Author(s):
- Samjoo IA, Worthington E, Drudge C, Zhao M, Cameron C, Häring DA, Stoneman D, Klotz L, Adlard N
- Publication Date:
- 2020
- Topic/Therapeutic Area:
- Multiple Sclerosis
Budget impact analysis of treatment‐free remission in nilotinib‐treated Japanese chronic myeloid leukemia patients
- Journal/Conference:
- Cancer Science
- Author(s):
- Yamazaki, K.: Inagaki, N.: Moldaver, D.: Viana, R.: Kimura, S.
- Publication Date:
- 2020
- Topic/Therapeutic Area:
- Blood, Oncology
Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany
- Journal/Conference:
- The Journal of Dermatological Treatment
- Author(s):
- Augustin, M.: Wirth, D.: Mahlich, J.: Pepper, A.N.: Druchok, C.
- Publication Date:
- 2020
- Topic/Therapeutic Area:
- Immune